• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Falls Over 200 Points; ISM Manufacturing PMI Rises In March

    4/1/24 10:39:56 AM ET
    $AEON
    $DOMA
    $EIGR
    $MDIA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Specialty Insurers
    Finance
    Get the next $AEON alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones falling over 200 points on Thursday.

    The Dow traded down 0.57% to 39,580.90 while the NASDAQ rose 0.30% to 16,427.97. The S&P 500 also fell, dropping, 0.07% to 5,250.56.

    Check This Out: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'


    Leading and Lagging Sectors

     

    Communication services shares jumped by 1.4% on Thursday.

    In trading on Thursday, real estate shares fell by 1.4%.

     

    Top Headline

     

    The ISM manufacturing PMI rose to 50.3 in March versus 47.8 in February and topping market estimates of 48.4.

     

    Equities Trading UP

     

    MediaCo Holding Inc. (NASDAQ:MDIA) shares shot up 52% to $0.7960 after dipping more than 17% on Thursday.

    Shares of Meta Materials Inc. (NASDAQ:MMAT) got a boost, surging 35% to $4.15. Meta Materials will host a corporate update webcast on Wednesday, April 3, 2024, at 4:30 PM EDT.

    Doma Holdings Inc. (NYSE:DOMA) shares were also up, gaining 34% to $6.09 after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.

     

    Equities Trading DOWN

     

    Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) shares dropped 41% to $2.93.

    Shares of AEON Biopharma, Inc. (NYSE:AEON) were down 41% to $6.86 after the company reported a fourth-quarter loss of 71 cents per share.

    Logistic Properties Of The Americas (NYSE:LPA) was down, falling 37% to $10.01.

    Also Check This Out: Bitcoin Trades Above $70,000 Following GDP, Jobless Claims Data; GateToken Emerges As Top Gainer


    Commodities

     

    In commodity news, oil traded up 0.2% to $83.35 while gold traded up 0.7% at $2,253.10.

    Silver traded up 0.1% to $24.94 on Thursday, while copper rose 1.2% to $4.0545.

    Economics

     

    The ISM Manufacturing PMI rose to 50.3 in March versus 47.8 in February and topping market estimates of 48.4.

    U.S. construction spending fell by 0.3% from the prior month in February.

    The S&P Global manufacturing PMI was revised lower to 51.9 in March compared to a preliminary reading of 52.5.

    Now Read This: $5M Bet On Snowflake? Check Out These 4 Stocks Insiders Are Buying

    Get the next $AEON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEON
    $DOMA
    $EIGR
    $MDIA

    CompanyDatePrice TargetRatingAnalyst
    AEON Biopharma Inc.
    $AEON
    8/18/2023$18.00Buy
    H.C. Wainwright
    Doma Holdings Inc.
    $DOMA
    12/15/2022$0.45Neutral
    Citigroup
    Doma Holdings Inc.
    $DOMA
    5/25/2022$2.00Neutral
    Compass Point
    Doma Holdings Inc.
    $DOMA
    5/16/2022Outperform → Perform
    Oppenheimer
    Doma Holdings Inc.
    $DOMA
    2/18/2022$14.00 → $7.50Buy
    DA Davidson
    Doma Holdings Inc.
    $DOMA
    2/2/2022Neutral
    BTIG
    Doma Holdings Inc.
    $DOMA
    9/17/2021$11.00Outperform
    Oppenheimer
    Doma Holdings Inc.
    $DOMA
    9/7/2021$11.00Buy
    Citigroup
    More analyst ratings

    $AEON
    $DOMA
    $EIGR
    $MDIA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on AEON Biopharma with a new price target

    H.C. Wainwright initiated coverage of AEON Biopharma with a rating of Buy and set a new price target of $18.00

    8/18/23 8:03:13 AM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Citigroup initiated coverage on Doma with a new price target

    Citigroup initiated coverage of Doma with a rating of Neutral and set a new price target of $0.45

    12/15/22 7:40:38 AM ET
    $DOMA
    Specialty Insurers
    Finance

    Compass Point initiated coverage on Doma with a new price target

    Compass Point initiated coverage of Doma with a rating of Neutral and set a new price target of $2.00

    5/25/22 7:15:40 AM ET
    $DOMA
    Specialty Insurers
    Finance

    $AEON
    $DOMA
    $EIGR
    $MDIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Daewoong Co., Ltd claimed ownership of 12,009,737 shares (SEC Form 3)

    3 - AEON Biopharma, Inc. (0001837607) (Issuer)

    1/29/26 9:25:12 PM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Standard General L.P. disposed of 2,105,596 shares (SEC Form 4)

    4 - Mediaco Holding Inc. (0001784254) (Issuer)

    9/12/25 4:53:23 PM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    Large owner Blackrock Portfolio Management Llc converted options into 28,206,152 shares and sold $282 worth of shares (214 units at $1.32) (SEC Form 4)

    4 - Mediaco Holding Inc. (0001784254) (Issuer)

    9/8/25 4:06:25 PM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    $AEON
    $DOMA
    $EIGR
    $MDIA
    SEC Filings

    View All

    SEC Form S-3 filed by AEON Biopharma Inc.

    S-3 - AEON Biopharma, Inc. (0001837607) (Filer)

    2/9/26 4:38:44 PM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AEON Biopharma Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AEON Biopharma, Inc. (0001837607) (Filer)

    1/21/26 4:06:10 PM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AEON Biopharma Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AEON Biopharma, Inc. (0001837607) (Filer)

    1/12/26 9:17:24 AM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEON
    $DOMA
    $EIGR
    $MDIA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fischer Jost bought $29,250 worth of shares (60,000 units at $0.49), increasing direct ownership by 29% to 266,785 units (SEC Form 4)

    4 - AEON Biopharma, Inc. (0001837607) (Issuer)

    5/23/25 4:46:16 PM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fischer Jost bought $55,300 worth of shares (110,000 units at $0.50), increasing direct ownership by 114% to 206,785 units (SEC Form 4)

    4 - AEON Biopharma, Inc. (0001837607) (Issuer)

    5/21/25 4:50:20 PM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Kayne Richard A bought $72,815 worth of shares (278,239 units at $0.26) (SEC Form 4)

    4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)

    11/2/23 9:21:30 PM ET
    $EIGR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEON
    $DOMA
    $EIGR
    $MDIA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MediaCo's EstrellaTV Rewrites History with Record-Breaking Prime Time Growth, Leading All Broadcast Networks in 2025

    MediaCo Holding Inc. (NASDAQ:MDIA) today announced that its flagship Spanish-language network, EstrellaTV, has achieved its largest annual Year-over-Year (YoY) P18-49 prime time percentage growth in network history at +14% for 2025. This historic gain marks the first annual growth for any Spanish-language TV broadcast network in the last four years. While the broader industry faced audience erosion, EstrellaTV's 14% surge stood in stark contrast to its primary competitors: Telemundo fell -7%, Univision dropped -8%, and UniMás declined -17%. "These historic numbers validate our strategic vision for MediaCo as a leader in the multicultural media space," said Soo Kim, Managing Partner, and

    2/12/26 9:27:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    MediaCo's EstrellaTV Extends Breakout Momentum to Start 2026, Delivering Category-Leading Prime Time Growth

    EstrellaTV, a division of MediaCo Holding Inc. (NASDAQ:MDIA), opened 2026 with decisive momentum, closing January with its fourth consecutive month of year-over-year prime time growth among Adults 18–49 and solidifying its position as the fastest-growing Spanish-language television network. So far this season, EstrellaTV has posted a +46% increase in prime time, the largest percentage gain among all major Spanish-language broadcasters. Over the same period, Telemundo delivered a +9% increase, while Univision and UniMás declined by -17% and -37%, respectively. Key Performance Highlights Prime Time Strength: EstrellaTV closed the final week of January averaging 33.2k Adults 18–49 viewe

    2/3/26 5:00:00 PM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    MediaCo Appoints Maire Mason to Lead Local Radio and Television Operations, Driving Major New York Market Shift

    Veteran Executive Joins MediaCo to Oversee NYC, Chicago, and Denver with Additional Expansion Planned MediaCo Holding Inc. (NASDAQ:MDIA) today announced the appointment of Maire Mason as Vice President and General Manager of Local MediaCo Markets, marking a significant leadership move in the New York radio and television landscape. In this role, Mason will oversee MediaCo's local radio and television operations across New York City, Chicago, and Denver, with responsibility for marquee brands including HOT 97 (WQHT-FM), WBLS-FM, Luna 107.5 (WBLS-HD2), La Buena (WQHT-HD2), and EstrellaTV's WMBC-TV in the New York tri-state area. MediaCo expects Mason's responsibilities to expand to additi

    1/26/26 8:00:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    $AEON
    $DOMA
    $EIGR
    $MDIA
    Leadership Updates

    Live Leadership Updates

    View All

    MediaCo Appoints Maire Mason to Lead Local Radio and Television Operations, Driving Major New York Market Shift

    Veteran Executive Joins MediaCo to Oversee NYC, Chicago, and Denver with Additional Expansion Planned MediaCo Holding Inc. (NASDAQ:MDIA) today announced the appointment of Maire Mason as Vice President and General Manager of Local MediaCo Markets, marking a significant leadership move in the New York radio and television landscape. In this role, Mason will oversee MediaCo's local radio and television operations across New York City, Chicago, and Denver, with responsibility for marquee brands including HOT 97 (WQHT-FM), WBLS-FM, Luna 107.5 (WBLS-HD2), La Buena (WQHT-HD2), and EstrellaTV's WMBC-TV in the New York tri-state area. MediaCo expects Mason's responsibilities to expand to additi

    1/26/26 8:00:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    MediaCo Appoints Albert Rodriguez to its Board of Directors

    MediaCo Holding Inc. (NASDAQ:MDIA) today announced the appointment of Albert Rodriguez to its Board of Directors. Mr. Rodriguez was previously appointed to President and Chief Executive Officer of MediaCo in early 2025. "Albert's appointment to our Board reflects our recognition of his contributions to our organization, as well as our alignment with his vision and leadership approach to charting our growth strategy," said Soo Kim, Founder of MediaCo and Standard General Managing Partner and Chief Investment Officer. "Since joining MediaCo, he has worked diligently to address our capital structure, set our priorities and drive the strategic direction of our company. His impact has been sub

    11/20/25 4:30:00 PM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    MediaCo Leads the Political Charge: Multicultural Audiences to Decide 2026 Election

    MediaCo Holding Inc. (NASDAQ:MDIA), a national leader in multicultural media, today announced the launch of its 2026 Political Team, a 100+ person powerhouse focused on political advertising and engagement in every local market, with special emphasis on swing states. Leveraging MediaCo's owned & operated stations, affiliates, digital platforms, hyper-focused live news in most markets and live news coverage in every market digitally, advanced data and analytics, and its exclusive partnership with Do It Outdoors, the company reaches voters across television, radio, streaming, and out-of-home (OOH) platforms using geofencing, shadow fencing, and mobile activation tools. A recent Miller Kapla

    10/7/25 9:15:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    $AEON
    $DOMA
    $EIGR
    $MDIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by AEON Biopharma Inc.

    SC 13G - AEON Biopharma, Inc. (0001837607) (Subject)

    11/14/24 5:05:14 PM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Eiger BioPharmaceuticals Inc. (Amendment)

    SC 13G/A - Eiger BioPharmaceuticals, Inc. (0001305253) (Subject)

    5/10/24 2:14:57 PM ET
    $EIGR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13D filed by Mediaco Holding Inc.

    SC 13D - Mediaco Holding Inc. (0001784254) (Subject)

    4/24/24 5:27:05 PM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    $AEON
    $DOMA
    $EIGR
    $MDIA
    Financials

    Live finance-specific insights

    View All

    AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

    – FDA Type 2a meeting scheduled for November 19, 2025, to review AEON's analytical development plan and initial data – – Positive biosimilarity data for ABP-450 confirming identical amino-acid sequencing and highly similar functional characteristics submitted to FDA ahead of scheduled Type 2a meeting – – Two complementary financing transactions announced in November 2025 - $6 million PIPE financing and a proposed Daewoong note exchange - are expected to strengthen AEON's balance sheet, reduce outstanding debt by more than 90%, accelerate the ABP-450 biosimilar program by up to six months, and extend cash runway into the second quarter of 2026 – IRVINE, Calif., Nov. 14, 2025 (GLOBE

    11/14/25 8:30:00 AM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update

    – Multiple near-term potential milestones, including anticipated completion of primary structure analysis and select functional analyses in 3Q'25 – – Type 2a meeting with the FDA anticipated in 4Q'25– – Cash runway expected to support operations through FDA meeting and regulatory feedback – IRVINE, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical company seeking an accelerated and full-label U.S. market entry by developing ABP-450 (prabotulinumtoxinA) as a BOTOX® (onabotulinumtoxinA) biosimilar, announced its financial results for the second quarter ended June 30, 2025, and provided a business update. "We have ma

    8/12/25 4:05:00 PM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

    – Continue to conduct analytical studies to prepare for a potential Biosimilar Biological Product Development ("BPD") Type 2a meeting with the FDA in the second half of 2025 – – Pursuing a 351(k) regulatory pathway for ABP-450, which offers potential access to the U.S. market under a single approval for all of BOTOX's currently approved and future therapeutic indications – – Appointed Rob Bancroft as the Company's President and Chief Executive Officer; Mr. Bancroft also joined AEON's Board of Directors – IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum

    5/14/25 4:05:00 PM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care